Contents

Current Pharmaceutical Design, Volume 16 - Number 11

Editorial [ Hot-topic: Molecularly Targeted Therapies in Breast Cancer Bone Metastases (Executive Editor: Philippe Clezardin)]

, 16(11): 1260 - 1261

Philippe Clezardin


DOI: 10.2174/138161210791033996




Bisphosphonates as Treatment of Bone Metastases

, 16(11): 1262 - 1271

Ingunn Holen and Robert E. Coleman


DOI: 10.2174/138161210791034003




Targeting RANK/RANKL in the Treatment of Solid Tumours and Myeloma

, 16(11): 1272 - 1283

C.H. Buckle, H.L. Neville-Webbe, P.I. Croucher and M.A. Lawson


DOI: 10.2174/138161210791034021




The CXCR4/SDF-1 Chemokine Axis: A Potential Therapeutic Target for Bone Metastases?

, 16(11): 1284 - 1290

A.C. Hirbe, E.A. Morgan and K.N. Weilbaecher


DOI: 10.2174/138161210791034012




Bone Morphogenetic Proteins and its Receptors; Therapeutic Targets in Cancer Progression and Bone Metastasis?

, 16(11): 1291 - 1300

Jeroen T. Buijs, Maj Petersen, Geertje van der Horst and Gabri van der Pluijm


DOI: 10.2174/138161210791033987




TGF-β Pathway as a Therapeutic Target in Bone Metastases

, 16(11): 1301 - 1312

Patricia Juarez and Theresa A. Guise


DOI: 10.2174/138161210791034049




Identification of Molecular Targets Associated with Ethanol Toxicity and Implications in Drug Development

, 16(11): 1313 - 1355

Lin-Lin Wang, An-Kui Yang, Shu-Ming He, Jun Liang, Zhi-Wei Zhou, Yong Li and Shu-Feng Zhou


DOI: 10.2174/138161210791034030




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science